OMED
OncoMed Pharmaceuticals, Inc.
OMED
OMED
Delisted
OMED was delisted on the 22nd of April, 2019.
58 hedge funds and large institutions have $88.1M invested in OncoMed Pharmaceuticals, Inc. in 2017 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 18 increasing their positions, 23 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
22% less repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 23
56% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 16
Holders
58
Holding in Top 10
1
Calls
$75K
Puts
$2K
Top Buyers
| 1 | +$4.69M | |
| 2 | +$705K | |
| 3 | +$463K | |
| 4 |
PP
PDT Partners
New York
|
+$420K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$402K |
Top Sellers
| 1 | -$14.7M | |
| 2 | -$1.66M | |
| 3 | -$646K | |
| 4 |
MWNA
Marshall Wace North America
New York
|
-$561K |
| 5 |
Two Sigma Investments
New York
|
-$486K |